Content on PharmTech.com this week ranged from fundamentals on the use of digital pathology in drug development, discussions on the use of AI in pharma, and regulatory actions impacting the industry.
|Articles|May 2, 2021
- Pharmaceutical Technology-05-02-2021
- Volume 45
- Issue 5
Inline High Shear Mixers from ROSS
Inline High Shear Mixers from ROSS are suitable for a wide range of dispersion, emulsification, and homogenization requirements
Inline High Shear Mixers from ROSS are suitable for a wide range of dispersion, emulsification, and homogenization requirements, while remaining completely portable and explosion-proof. The models can be equipped with a NEMA 7/9 operator station pre-wired and mounted to the mobile mixer cart. The controls can be customized to include a viewing window for process variables and intrinsically safe thermocouple, which is attached to the motor’s internal thermal switch. Kalrez elastomers allow the mixer to be used in extreme-duty processes with chemically aggressive fluids. Stainless steel construction, sanitary tri-clamp connections, 3A stamps, double mechanical seal, and washdown motors are also available.
Articles in this issue
over 5 years ago
Injecting Innovation into Drug Packagingover 5 years ago
QbD Helps Evaluate Excipient Variabilityover 5 years ago
Overcoming Vaccine Development Challengesover 5 years ago
Beyond Lyophilizationover 5 years ago
Track-and-Trace Progress Benefits Supply-Chain Security Effortsover 5 years ago
Responding to FDA CAPA Requestsover 5 years ago
Evolving Analytical Technology Unravels Protein Characteristicsover 5 years ago
FDA and Industry Move to Renew New Drug User Fee ProgramsRelated to this article
This article discusses risk-based lifecycle governance, system implementation considerations, and the progression of batch record control from paper-based to fully electronic systems.
Ronald Piervincenzi, USP, explains why manufacturers should act now and how benchmarking could reward reliable generic drug suppliers.
The FDA approves Lilly's once-weekly insulin efsitora for type 2 diabetes, raising Fc-fusion manufacturing, high-concentration pen, and capacity questions.
Florin Muraru, Gourav Pandey, and Richard Jaenisch explain where human sign-off belongs as multi-agent AI and document-parsing models reach GxP.
In this episode of Ask the Expert, Siegfried Schmitt, PhD, vice president, Technical at Parexel, and Susan J. Schniepp, distinguished fellow at Nelson Labs, discuss how companies should approach post-approval changes to their CMC regulatory filings.
The EC has approved AstraZeneca's Trixeo Aerosphere as the first single-inhaler triple-combination therapy for asthma in the EU, based on phase e data showing improved lung function and fewer severe exacerbations in patients uncontrolled on standard ICS/LABA treatment.
In this episode of Pharma Fundamentals, Dr. Aleksandra Zuraw, senior veterinary pathologist at Charles River, provides an introduction to the use of digital pathology in drug development.
Trending on Pharmaceutical Technology
1
Risk-Based Life Cycle Management of Master Production and Control Records to Strengthen Data Integrity and GMP Inspection Readiness Part 2: Practical Considerations for CGMP Documentation Systems
2
The FDA Finalizes Rule Recognizing Non-Animal Testing Methods, Building on Year-Long Reduction Push
3
PharmTech AI Pulse Check: Validating Multi-Agent Systems, OCR Models in GxP
4
CPHI Milan: USP Benchmarks Reshape Procurement Incentives
5